Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
12.9M
-
Shares change
-
-149K
-
Total reported value, excl. options
-
$67.3M
-
Value change
-
-$773K
-
Put/Call ratio
-
0
-
Number of buys
-
13
-
Number of sells
-
-25
-
Price
-
$5.23
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q4 2014
48 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q4 2014.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.9M shares
of 71.9M outstanding shares and own 17.93% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.39M shares), ORBIMED ADVISORS LLC (2.82M shares), RENAISSANCE TECHNOLOGIES LLC (1.18M shares), Pine River Capital Management L.P. (1.1M shares), FIL Ltd (1.07M shares), BlackRock Fund Advisors (662K shares), PICTET ASSET MANAGEMENT LTD (306K shares), DEUTSCHE BANK AG\ (158K shares), Citadel Advisors LLC (156K shares), and Invesco Ltd. (144K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.